Laura Brege - 16 Jun 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Director
Signature: /s/John R. Moore Attorney-in-Fact for Laura A. Brege
Issuer symbol: EWTX
Transactions as of: 16 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 18 Jun 2025, 19:37:28 UTC
Previous filing: 13 Jun 2025
Next filing: 12 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Brege Laura	Director	C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER	/s/John R. Moore Attorney-in-Fact for Laura A. Brege	18 Jun 2025	0001365619

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EWTX	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	16 Jun 2025	Common Stock	30,000	$14.68	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders.